What is Tadalafil?
Tadalafil is an FDA-approved oral phosphodiesterase type 5 (PDE5) inhibitor used primarily to treat erectile dysfunction (ED), benign prostatic hyperplasia (BPH), and pulmonary arterial hypertension. 1
Mechanism of Action
Tadalafil works as a selective inhibitor of cyclic guanosine monophosphate (cGMP)-specific phosphodiesterase type 5 (PDE5). By blocking this enzyme, it enhances the effects of nitric oxide, leading to increased blood flow to the penis during sexual stimulation and helping men achieve and maintain erections satisfactory for sexual activity. 1, 2
The drug has high selectivity for PDE5 versus other phosphodiesterase isoforms (PDE1-4), and notably shows greater selectivity against PDE6 compared to sildenafil—which translates to fewer visual side effects. 2
FDA-Approved Indications
According to FDA labeling and clinical guidelines, tadalafil is approved for: 1, 3
- Erectile dysfunction (ED) in men over age 18
- Benign prostatic hyperplasia (BPH) symptoms
- Combined ED and BPH in the same patient
- Pulmonary arterial hypertension (marketed as Adcirca)
Unique Pharmacokinetic Properties
Tadalafil has a significantly longer half-life (17.5 hours) compared to other PDE5 inhibitors, with active drug remaining in the body for more than 2 days after a single dose. 1, 4 This extended duration allows for:
- Once-daily dosing options
- Effectiveness up to 24-36 hours post-dosing
- More spontaneous sexual activity without strict timing requirements
- Food and alcohol have minimal impact on absorption
Both on-demand and daily dosing regimens show similar efficacy. 3
Clinical Efficacy
Multiple large-scale trials involving nearly 250,000 men demonstrate that tadalafil has similar efficacy to other PDE5 inhibitors (sildenafil, vardenafil, avanafil) in the general ED population. 3 However, men with diabetes or post-prostatectomy status have more severe baseline ED and respond less robustly to all PDE5 inhibitors.
Recent evidence suggests tadalafil may provide additional cardiovascular and cognitive benefits beyond ED treatment, with reduced risks of all-cause mortality, myocardial infarction, stroke, and dementia in men with ED. 5
Common Side Effects
The most frequently reported adverse events include: 3
- Headache
- Flushing (lowest rates with tadalafil compared to other PDE5i)
- Dyspepsia
- Back pain
- Nasal congestion
- Myalgia
- Visual disturbances
- Dizziness
Most side effects follow a dose-response pattern and are generally mild.
Critical Contraindications
Never prescribe tadalafil to patients taking nitrates or guanylate cyclase stimulators (like riociguat)—this combination can cause life-threatening hypotension, leading to dizziness, fainting, heart attack, or stroke. 1
Additional contraindications include:
- Allergy to tadalafil or its components
- Use of recreational "poppers" (amyl nitrite, butyl nitrite)
- Patients advised against sexual activity due to cardiovascular risk
Special Populations Requiring Caution
Use lower initial doses or avoid tadalafil in: 3
- Severe renal or hepatic disease
- Mild-to-moderate hepatic/renal impairment (start with lower doses)
- Spinal cord injury patients
- Men with cardiovascular disease, recent stroke, or uncontrolled hypertension
Important Clinical Pearls
Sexual stimulation is required for tadalafil to work—it does not increase sexual desire, cure ED, or provide contraception/STD protection. 1
The drug should be titrated to optimal efficacy, and patients must receive proper instructions on use to maximize benefit, as incorrect usage (lack of sexual stimulation, taking with large meals) accounts for many treatment failures. 3
Beyond Urology
Emerging evidence suggests potential applications in: 2, 6
- Circulatory disorders (ischemia, myocardial infarction, heart failure)
- Neurodegenerative disorders
- Cognitive impairment conditions
- Pulmonary hypertension (WHO Group 1)
However, trials in heart failure with preserved ejection fraction have shown mixed results. 6